Effect of a Daily Life Activity-Based Awareness Training Program on Hypertensive Individuals
Effect of an Education Program Based on the Roper, Logan, and Tierney Model of Daily Living Activities Supported With Mindfulness on Self Care, Treatment Adherence, and Healthy Lifestyle Behaviors in Hypertensive Individuals
1 other identifier
interventional
70
1 country
1
Brief Summary
This randomized controlled study evaluated an education program based on the Roper, Logan, and Tierney model of daily living activities, supported by mindfulness, for hypertensive individuals. The intervention group received eight weeks of online sessions, while the control group received routine care. Results showed significant improvements in systolic and diastolic blood pressure, self-care, treatment adherence, and healthy lifestyle behaviors in the intervention group compared to controls (p\<0.05). Findings suggest that mindfulness-supported education enhances hypertension management. Further studies with larger samples and long-term follow-up are recommended.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable hypertension
Started Mar 2023
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 15, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 15, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
July 5, 2024
CompletedFirst Submitted
Initial submission to the registry
August 4, 2024
CompletedFirst Posted
Study publicly available on registry
August 9, 2024
CompletedAugust 9, 2024
August 1, 2024
2 months
August 4, 2024
August 8, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
Hypertension Self-Care Profile
The Hypertension Self-Care Profile Scale has three subscales: behavior, motivation and self-efficacy. In this scale, each sub-dimension is evaluated separately and a total of minimum 20 and maximum 80 points can be obtained from the scale. Higher scores indicate better self-care.
At week 0, week 8 and week 12
Hill-Bone Hypertension Treatment Compliance Scale
The scale consists of three sub-dimensions (interview, medical and nutrition) and a total of 14 questions. The total score that can be obtained from the scale varies between 14 and 56; A score of 14 indicates full compliance, while higher scores indicate treatment non-compliance.
At week 0, week 8 and week 12
Healthy Lifestyle Behaviors Scale II
It aims to evaluate individuals' behaviors towards healthy lifestyles. There are 52 items in total in the scale, and all of the items consist of positive expressions. The minimum score that can be obtained from the scale is 52 and the maximum score is 208.
At week 0, week 8 and week 12
Conscious awareness
It evaluates individual differences in individuals' states of consciousness and measures their tendency to be aware of and pay attention to momentary experiences in daily life. The total score that can be obtained varies between 15 and 90. A high score indicates a high level of conscious awareness.
At week 0, week 8 and week 12
Secondary Outcomes (3)
Systolic and diastolic blood pressure
At week 0, week 8 and week 12
Metabolic Control Variables
At week 0 and week 8
Hypertension Information Assessment
At week 0 and week 8
Study Arms (2)
Intervention group
EXPERIMENTALOne session per week; 20 minutes for the training module and 25 minutes for the awareness practice, a total of 45 minutes each week, for a total of 8 weeks.
Control group
NO INTERVENTIONUsual care.
Interventions
The HT self-management training program was continued in the form of one session per week, a total of 8 modules, for 8 weeks, with different module content each week. After these eight-week training and awareness sessions were completed, the implementation of the study was terminated (week 8), no additional intervention was given to the intervention group, and the evaluations at the 8th week (end of intervention-T1) and the 12th week (follow-up-T2) were carried out by the researcher during the routine checks of the participants at the outpatient clinic. It was carried out face to face.
Eligibility Criteria
You may qualify if:
- Aged between 18 and 65
- Literate (able to read and write)
- Followed up for at least 6 months with a diagnosis of stage 1 primary hypertension (HT)
- Taking at least one antihypertensive medication
- No changes in antihypertensive medication in the past month
- Able to use a smartphone and WhatsApp® application
- Having internet access and willing to participate in online sessions
You may not qualify if:
- Those with hearing and vision problems
- Those with cognitive impairment
- Having a psychiatric diagnosis such as major depression
- Having a history of major heart surgery in the last 6 months
- Those with severe symptom burden due to advanced COPD, heart failure, asthma, cancer
- Individuals who used another mind-body-based approach (yoga, meditation, relaxation exercise, etc.) during the research were not included in the sample.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Ornek Mahallesi, 2061. Caddesi 4/1 Blok No:37
Altındağ, Ankara, 06080, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Hacer Eroğlu
haceroturmaz@hacettepe.edu.tr
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, OUTCOMES ASSESSOR
- Masking Details
- Blinding of Participants: Blinding of participants means that the individuals taking part in the study are not aware of which group they have been assigned to, whether it is the intervention group or the control group. This helps to prevent bias in their behavior and responses, as they do not know if they are receiving the actual treatment or a placebo. Blinding of Outcome Assessors: Blinding of outcome assessors involves keeping the individuals who are measuring and assessing the results of the study unaware of which participants belong to the intervention or control group. This is done to ensure that the data collected and the evaluations made are not influenced by any preconceived notions or expectations about the effectiveness of the intervention.
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Doctoral Student
Study Record Dates
First Submitted
August 4, 2024
First Posted
August 9, 2024
Study Start
March 15, 2023
Primary Completion
May 15, 2023
Study Completion
July 5, 2024
Last Updated
August 9, 2024
Record last verified: 2024-08
Data Sharing
- IPD Sharing
- Will not share
Researchers interested in accessing the IPD should contact the study's principal investigator via email at \[email address\]. Requests will be reviewed and responded to within four weeks.